Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
190.00    3.00 (1.62%)
Bid:
185.00
Ask:
195.00
Spread: 10.00 (5.405%)
Market Cap: £99.47m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

14 Jul 2020 07:00

RNS Number : 8834S
Somero Enterprises Inc.
14 July 2020
 

14 July 2020

Somero Enterprises, Inc.

("Somero" or the "Company")

 

Trading Update

Somero is pleased to provide an update on trading ahead of its interim results announcement scheduled to be released on Wednesday, 9 September 2020.

Trading for H1 2020 ended in line with the level detailed in the Company's announcement of 5 June 2020, approximately 25% below levels required to achieve the market expectation at the start of the year of US$ 90.0m in 2020 revenues.

Following the cost reduction actions implemented by Management, the Company remains profitable and cash generative at current volumes and the Board remains confident the Company would continue to be cash generative even in the scenario where revenues fall an additional 20% from current levels. The cost saving actions taken by Management were specifically designed to not impact investment in new product development, a key element to the Company's long-term growth strategy. New product development activity remains at a high level and the Company continues to add to its product offering. The latest examples are the SRS-4 compact Boom Laser Screed® Machine launched in H1 2020 that has quickly gained encouraging market interest and contributed meaningfully to H1 2020 sales, and the introduction in late June 2020 of the innovative Somero Broom + Cure™ machine that replaces manual effort in the broom and cure process on exterior concrete slabs with efficient, consistent machine application.

The Company's financial position remains secure, highlighted by net cash as at 30 June 2020 of at least US$ 28.0m, exceeding the conservative US$ 24.0m net cash expectation outlined in the 5 June 2020 update. The strong operational cash flow performance reflects effective working capital management driven by healthy trade receivable collections to end the first half of the year.

The uncertainty around the scale, duration and impact of the COVID-19 pandemic on Somero's end markets in the non-residential construction industry continues to make it difficult at this time to provide further guidance on the Company's financial performance in the rest of 2020 and beyond. While extended project backlogs reported by our customers prior to the COVID-19 pandemic, particularly in the US, indicate the non-residential construction market was active and healthy entering this period, financial performance for 2020 and beyond will depend on a number variables over which the Company has no control. The Company will provide updates as appropriate regarding the outlook for the business once greater clarity is attained.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Enquiries:

 

 

Somero Enterprises, Inc.

Jack Cooney, CEO

John Yuncza, CFO

Howard Hohmann, EVP Sales

www.somero.com

+1 239 210 6500

 

 

finnCap Ltd (NOMAD and Broker)

Matt Goode (Corporate Finance)

Kate Bannatyne (Corporate Finance)

Tim Redfern (Corporate Broking)

+44 (0)20 7220 0500

 

Alma PR (Financial PR Advisor)

Rebecca Sanders-Hewett

Susie Hudson

Sam Modlin

David Ison

somero@almapr.co.uk

+44 (0)20 3405 0205

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKNBBDBKBFOD
Date   Source Headline
5th Jun 20267:00 amRNSAGM Statement
4th Jun 20267:47 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jun 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
28th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
20th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
14th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20262:53 pmRNSHolding(s) in Company
7th May 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20265:39 pmRNSUpdate regarding Company Shareholdings
30th Apr 20261:44 pmRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20267:00 amRNSNotice of AGM & Director Succession Update
27th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Apr 20267:00 amRNSHolding(s) in Company
21st Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20269:08 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSBuyback Expansion and Further M&A Framework Detail
9th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Mar 20265:27 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Mar 20269:01 amRNSHolding(s) in Company
26th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Mar 20267:00 amRNSHolding(s) in Company
24th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20267:00 amRNSLaunch of 2026 Share Buyback Programme
12th Mar 20267:00 amRNSLaunch of 2026 Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
17th Feb 20267:00 amRNSNotice of Investor Presentation
29th Jan 20267:00 amRNSTrading Update
20th Jan 20267:41 amRNSHolding(s) in Company
19th Dec 20252:28 pmRNSTransaction in Own Shares and Total Voting Rights
19th Dec 20252:28 pmRNSTransaction in Own Shares and Total Voting Rights
18th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20251:30 pmRNSTransaction in Own Shares and Total Voting Rights
5th Dec 20257:00 amRNSHolding(s) in Company
4th Dec 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Nov 20259:01 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.